BXM to merge with GZTR, GZSP

Genzyme Tissue Repair (GZTR), Genzyme Surgical Products (GZSP) and Biomatrix (BXM) will merge to form Genzyme Biosurgery, a new division of Genzyme. The merged company will have 22 marketed products, including BXM's Synvisc viscosupplementation product to treat osteoarthritis of the knee, GZTR's Carticel autologous cultured chondrocytes to treat damaged knee cartilage and GZSP's Seprafilm to reduce post-surgical adhesions. ...